Self-assembling protein nanoparticles in the design of vaccines

Abstract

For over 100 years, vaccines have been one of the most effective medical interventions for reducing infectious disease, and are estimated to save millions of lives globally each year. Nevertheless, many diseases are not yet preventable by vaccination. This large unmet medical need demands further research and the development of novel vaccines with high efficacy and safety. Compared to the 19th and early 20th century vaccines that were made of killed, inactivated, or live-attenuated pathogens, modern vaccines containing isolated, highly purified antigenic protein subunits are safer but tend to induce lower levels of protective immunity. One strategy to overcome the latter is to design antigen nanoparticles: assemblies of polypeptides that present multiple copies of subunit antigens in well-ordered arrays with defined orientations that can potentially mimic the repetitiveness, geometry, size, and shape of the natural host-pathogen surface interactions. Such nanoparticles offer a collective strength of multiple binding sites (avidity) and can provide improved antigen stability and immunogenicity. Several exciting advances have emerged lately, including preclinical evidence that this strategy may be applicable for the development of innovative new vaccines, for example, protecting against influenza, human immunodeficiency virus, and respiratory syncytial virus. Here, we provide a concise review of a critical selection of data that demonstrate the potential of this field. In addition, we highlight how the use of self-assembling protein nanoparticles can be effectively combined with the emerging discipline of structural vaccinology for maximum impact in the rational design of vaccine antigens.

Cited by papers we hold 12

• Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases · 2022
  No notice
• A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections · 2021
  Not checked
• Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice · 2021
  No notice
• Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection · 2021
  No notice
• Protein-based antigen presentation platforms for nanoparticle vaccines · 2021
  No notice
• pH-Sensitive Biomaterials for Drug Delivery · 2020
  No notice
• Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens · 2020
  No notice
• Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2 · 2020
  No notice
• Therapeutic Nanoparticles and Their Targeted Delivery Applications · 2020
  No notice
• Nanoparticle-Based Vaccines Against Respiratory Viruses · 2019
  No notice
• Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus · 2019
  No notice
• Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.